Dimensional Fund Advisors Cuts Stake in Rhythm Pharmaceuticals
Dimensional Fund Advisors LP recently reduced its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) by selling 12,867 shares during the first quarter. This represents a 40.2% decrease in their holdings.
The fund now owns 19,151 shares of the company's stock, valued at $1,666,000. Other hedge funds also made significant changes to their positions in Rhythm Pharmaceuticals during the same period.
AlphaCentric Advisors LLC increased its stake by 84.0% and now owns 9,297 shares worth $809,000. Swiss National Bank boosted its holdings by 0.8%, purchasing an additional 900 shares for a total of 112,200 shares valued at $9,758,000.